republic-os/legislation/us/states/tn/114/hb-1198.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.	Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.	us/states/tn	Tennessee General Assembly	114	HB 1198	Tennessee HB 1198 (114)	bill	Drugs Prescription	enacted	Kumar	3	25	5	2025-02-06	2025-04-28	openstates	ocd-bill/cf2c3791-070f-4744-bc47-0bc640a13c9c	https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1198&ga=114	b568d9f58d08aee2d46e562d2cb0c11f02753ff3935c8721f941dcb9221af4c2	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-tn

Tennessee HB 1198 (114) — Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Amendment HA0140 (committee substitute) — source
2. Amendment SA0236 (committee substitute) — source
3. Current Version (committee substitute) — source

Votes

• INSURANCE SUBCOMMITTEE: Rec for pass if am by s/c ref. to Insurance Committee 3/12/2025 Passed (3) — 6–0 (pass) · lower
• HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 3/31/2025 3/27/2025 (2) — 0–0 (fail) · lower
• FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 3/31/2025 Passed (1) — 92–1 (pass) · lower
• HOUSE INSURANCE COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee 3/19/2025 Passed — 15–0 (pass) · lower
• FLOOR VOTE: Third Consideration 3/31/2025 Passed (1) — 30–0 (pass) · upper

Sponsors

• Kumar — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-02-06 Filed for introduction filing
• 2025-02-10 Intro., P1C. introduction
• 2025-02-12 Assigned to s/c Insurance Subcommittee referral-committee
• 2025-02-12 P2C, ref. to Insurance Committee referral-committee
• 2025-03-05 Placed on s/c cal Insurance Subcommittee for 3/12/2025
• 2025-03-12 Placed on cal. Insurance Committee for 3/19/2025
• 2025-03-12 Rec for pass if am by s/c ref. to Insurance Committee referral-committee
• 2025-03-19 Rec. for pass. if am., ref. to Calendar & Rules Committee committee-passage-favorable
• 2025-03-26 Placed on cal. Calendar & Rules Committee for 3/27/2025
• 2025-03-27 H. Placed on Regular Calendar for 3/31/2025
• 2025-03-31 Passed Senate, Ayes 30, Nays 0 passage
• 2025-03-31 Amendment withdrawn. (Amendment 1 - SA0236)
• 2025-03-31 Senate substituted House Bill for companion Senate Bill. substitution
• 2025-03-31 Received from House, Passed on First Consideration introduction
• 2025-03-31 Engrossed; ready for transmission to Sen. receipt
• 2025-03-31 Passed H., as am., Ayes 92, Nays 1, PNV 0 passage
• 2025-03-31 Sponsor(s) Added. sponsorship
• 2025-03-31 H. adopted am. (Amendment 1 - HA0140) amendment-passage
• 2025-04-02 Signed by H. Speaker passage
• 2025-04-02 Enrolled; ready for sig. of H. Speaker. enrolled
• 2025-04-03 Transmitted to Governor for his action. executive-receipt
• 2025-04-03 Signed by Senate Speaker passage
• 2025-04-11 Signed by Governor. executive-signature
• 2025-04-28 Effective date(s) 04/11/2025
• 2025-04-28 Pub. Ch. 206

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/cf2c3791-070f-4744-bc47-0bc640a13c9c. Confidence: reported (aggregated from official Tennessee legislature records).